Evidence map›Paper›PMID 41145660›Full record

Articlenpj antimicrobials and resistance2025

Lipopolysaccharide clustering in colistin persistent and resistant bacteria.

Fengyi Wang, George Merces, Dominic Alderson, Adam J M Wollman, Mark Geoghegan, Chien-Yi Chang

Abstract read
In one paragraph

Article in npj antimicrobials and resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Phage-Based Approaches to ChronicAntibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fengyi WangSchool of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
George MercesBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Dominic AldersonBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Adam J M WollmanBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
Mark GeogheganSchool of Engineering, Newcastle University, Newcastle Upon Tyne, UK.
Chien-Yi ChangSchool of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK. chienyi.chang@newcastle.ac.uk.

Funding

National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC) Infrastructural supportWellcome TrustWellcome Trust Institutional Strategic Support Fund 204787/Z/16/Z
6 · The paper itself

Abstract

Polymyxin antibiotics target lipopolysaccharides (LPS) in Gram-negative bacteria, but persistence and mcr-mediated resistance increasingly compromise their therapeutic efficacy. Here, we use super-resolution localisation microscopy to investigate the nanoscale organisation of LPS and membrane lipids in colistin-persistent Escherichia Pseudomonas aeruginosa. We find that persister cells exhibit heterogeneous LPS and membrane lipid distributions, with localised LPS clustering along the cell envelope, compared to susceptible cells. Unexpectedly, mcr-1-positive E. coli displays a similar LPS clustering phenotype to that of persisters, without altering membrane organisation. These findings suggest that both persistence and resistance involve envelope reorganisation, with increased LPS clustering and remodelling observed in both E. coli and P. aeruginosa. This work reveals a morphological signature of persistence and identifies a shared feature between persistence and resistance in Gram-negative bacteria.

Identifiers

PMID41145660
PMCPMC12559395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.